JP2017048155A - Dkk1発現促進剤および美白剤 - Google Patents
Dkk1発現促進剤および美白剤 Download PDFInfo
- Publication number
- JP2017048155A JP2017048155A JP2015174214A JP2015174214A JP2017048155A JP 2017048155 A JP2017048155 A JP 2017048155A JP 2015174214 A JP2015174214 A JP 2015174214A JP 2015174214 A JP2015174214 A JP 2015174214A JP 2017048155 A JP2017048155 A JP 2017048155A
- Authority
- JP
- Japan
- Prior art keywords
- dkk1
- dkk1 expression
- extract
- expression promoting
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102100030074 Dickkopf-related protein 1 Human genes 0.000 title claims abstract description 65
- 230000001737 promoting effect Effects 0.000 title claims abstract description 32
- 230000002087 whitening effect Effects 0.000 title claims abstract description 28
- 101710099518 Dickkopf-related protein 1 Proteins 0.000 title description 2
- 101000864646 Homo sapiens Dickkopf-related protein 1 Proteins 0.000 claims abstract description 63
- 239000000284 extract Substances 0.000 claims abstract description 34
- 235000009008 Eriobotrya japonica Nutrition 0.000 claims abstract description 25
- 229940109850 royal jelly Drugs 0.000 claims abstract description 24
- 239000004480 active ingredient Substances 0.000 claims abstract description 17
- 229930014626 natural product Natural products 0.000 claims abstract description 15
- 244000061508 Eriobotrya japonica Species 0.000 claims abstract description 5
- 241000202807 Glycyrrhiza Species 0.000 claims description 31
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 30
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 30
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 30
- 229940010454 licorice Drugs 0.000 claims description 30
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 24
- 244000144730 Amygdalus persica Species 0.000 claims description 22
- 235000006040 Prunus persica var persica Nutrition 0.000 claims description 22
- 208000037386 Typhoid Diseases 0.000 claims description 5
- 201000008297 typhoid fever Diseases 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 abstract description 33
- 239000004615 ingredient Substances 0.000 abstract description 4
- 235000013411 Alpinia speciosa Nutrition 0.000 abstract description 3
- 239000007844 bleaching agent Substances 0.000 abstract description 3
- 235000008529 Ziziphus vulgaris Nutrition 0.000 abstract description 2
- 230000009471 action Effects 0.000 abstract description 2
- 244000060696 Alpinia speciosa Species 0.000 abstract 1
- 240000008917 Glycyrrhiza uralensis Species 0.000 abstract 1
- 235000000554 Glycyrrhiza uralensis Nutrition 0.000 abstract 1
- 240000000038 Ziziphus mauritiana Species 0.000 abstract 1
- 235000006545 Ziziphus mauritiana Nutrition 0.000 abstract 1
- 238000000605 extraction Methods 0.000 description 25
- 241001092070 Eriobotrya Species 0.000 description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 18
- 239000000203 mixture Substances 0.000 description 14
- 239000002994 raw material Substances 0.000 description 14
- 239000002904 solvent Substances 0.000 description 11
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 10
- 102000013814 Wnt Human genes 0.000 description 10
- 239000003814 drug Substances 0.000 description 9
- 230000019491 signal transduction Effects 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 8
- 210000002615 epidermis Anatomy 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 235000013305 food Nutrition 0.000 description 7
- 210000002752 melanocyte Anatomy 0.000 description 7
- 108020004999 messenger RNA Proteins 0.000 description 7
- 238000002156 mixing Methods 0.000 description 7
- 210000003491 skin Anatomy 0.000 description 7
- 239000007788 liquid Substances 0.000 description 6
- 230000035755 proliferation Effects 0.000 description 6
- 238000011282 treatment Methods 0.000 description 6
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 5
- 208000012641 Pigmentation disease Diseases 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 230000002500 effect on skin Effects 0.000 description 5
- 210000002950 fibroblast Anatomy 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 230000019612 pigmentation Effects 0.000 description 5
- 241000256844 Apis mellifera Species 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 230000004069 differentiation Effects 0.000 description 4
- 230000008099 melanin synthesis Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- 206010009944 Colon cancer Diseases 0.000 description 3
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- -1 aliphatic alcohols Chemical class 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 210000005175 epidermal keratinocyte Anatomy 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000002798 polar solvent Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 210000001626 skin fibroblast Anatomy 0.000 description 3
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 241000256836 Apis Species 0.000 description 2
- 244000105624 Arachis hypogaea Species 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 244000041517 Etlingera elatior Species 0.000 description 2
- 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 2
- 239000004378 Glycyrrhizin Substances 0.000 description 2
- 102000006757 Wnt Receptors Human genes 0.000 description 2
- 108010047118 Wnt Receptors Proteins 0.000 description 2
- 244000126002 Ziziphus vulgaris Species 0.000 description 2
- 239000012752 auxiliary agent Substances 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000012937 correction Methods 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 238000005238 degreasing Methods 0.000 description 2
- RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 235000013376 functional food Nutrition 0.000 description 2
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 description 2
- 235000019410 glycyrrhizin Nutrition 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000005342 ion exchange Methods 0.000 description 2
- 210000002510 keratinocyte Anatomy 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 235000020232 peanut Nutrition 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 239000012264 purified product Substances 0.000 description 2
- 238000003757 reverse transcription PCR Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- 241000256837 Apidae Species 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 241000257303 Hymenoptera Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 244000062730 Melissa officinalis Species 0.000 description 1
- 235000010654 Melissa officinalis Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000244206 Nematoda Species 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 241000219100 Rhamnaceae Species 0.000 description 1
- 235000004789 Rosa xanthina Nutrition 0.000 description 1
- 241000220222 Rosaceae Species 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000001668 ameliorated effect Effects 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical compound CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 239000002349 well water Substances 0.000 description 1
- 235000020681 well water Nutrition 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
本実施形態のDKK1発現促進剤は、月桃葉部、甘草葉部、タイソウ、ローヤルゼリー、およびビワからなる群より選択される1種または2種以上の天然物からの抽出物を有効成分として含有するものである。また、本実施形態の美白剤は、DKK1発現促進作用に基づくものであり、月桃葉部、甘草葉部、タイソウ、ローヤルゼリー、およびビワからなる群より選択される1種または2種以上の天然物からの抽出物を有効成分として含有するものである。
上記天然物抽出物(試料1〜5)について、以下のようにしてDKK1mRNA発現促進作用を試験した。
式中の各項はそれぞれ以下を表す。
A:被験試料添加での補正値
B:試料無添加での補正値
結果を表2に示す。
Claims (2)
- 月桃葉部、甘草葉部、タイソウ、ローヤルゼリー、およびビワからなる群より選択される1種または2種以上の天然物からの抽出物を有効成分として含有することを特徴とするDKK1発現促進剤。
- 月桃葉部、甘草葉部、タイソウ、ローヤルゼリー、およびビワからなる群より選択される1種または2種以上の天然物からの抽出物を有効成分として含有することを特徴とするDKK1発現促進作用に基づく美白剤。
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2015174214A JP6846106B2 (ja) | 2015-09-03 | 2015-09-03 | Dkk1発現促進剤および美白剤 |
JP2020026081A JP7402509B2 (ja) | 2015-09-03 | 2020-02-19 | Dkk1発現促進剤および美白剤 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2015174214A JP6846106B2 (ja) | 2015-09-03 | 2015-09-03 | Dkk1発現促進剤および美白剤 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2020026081A Division JP7402509B2 (ja) | 2015-09-03 | 2020-02-19 | Dkk1発現促進剤および美白剤 |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2017048155A true JP2017048155A (ja) | 2017-03-09 |
JP2017048155A5 JP2017048155A5 (ja) | 2018-09-13 |
JP6846106B2 JP6846106B2 (ja) | 2021-03-24 |
Family
ID=58279178
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2015174214A Active JP6846106B2 (ja) | 2015-09-03 | 2015-09-03 | Dkk1発現促進剤および美白剤 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6846106B2 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2019182845A (ja) * | 2018-04-02 | 2019-10-24 | 学校法人藤田学園 | キヌレニンアミノトランスフェラーゼ2(kat2)阻害剤 |
JP7454355B2 (ja) | 2018-12-27 | 2024-03-22 | ロート製薬株式会社 | Dkk1産生促進剤及びその製造方法、dkk1産生促進用美容組成物及びその製造方法、並びにdkk1産生促進方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07126149A (ja) * | 1993-10-28 | 1995-05-16 | Suntory Ltd | 美白用化粧料組成物 |
JP2005029494A (ja) * | 2003-07-10 | 2005-02-03 | Fancl Corp | メラノサイト増殖抑制剤およびこれを含む化粧料 |
JP2006008646A (ja) * | 2004-06-24 | 2006-01-12 | Eiji Yoda | 化粧料 |
JP2008013481A (ja) * | 2006-07-05 | 2008-01-24 | Univ Of Tokushima | ゲットウ(Alpiniaspeciosa)由来のチロシナーゼ活性阻害剤及びリポキシゲナーゼ活性阻害剤 |
JP2013166713A (ja) * | 2012-02-14 | 2013-08-29 | Ichimaru Pharcos Co Ltd | キネシン抑制剤 |
JP2014019683A (ja) * | 2012-07-23 | 2014-02-03 | Ichimaru Pharcos Co Ltd | メラニン含有ケラチノサイト***促進剤 |
-
2015
- 2015-09-03 JP JP2015174214A patent/JP6846106B2/ja active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07126149A (ja) * | 1993-10-28 | 1995-05-16 | Suntory Ltd | 美白用化粧料組成物 |
JP2005029494A (ja) * | 2003-07-10 | 2005-02-03 | Fancl Corp | メラノサイト増殖抑制剤およびこれを含む化粧料 |
JP2006008646A (ja) * | 2004-06-24 | 2006-01-12 | Eiji Yoda | 化粧料 |
JP2008013481A (ja) * | 2006-07-05 | 2008-01-24 | Univ Of Tokushima | ゲットウ(Alpiniaspeciosa)由来のチロシナーゼ活性阻害剤及びリポキシゲナーゼ活性阻害剤 |
JP2013166713A (ja) * | 2012-02-14 | 2013-08-29 | Ichimaru Pharcos Co Ltd | キネシン抑制剤 |
JP2014019683A (ja) * | 2012-07-23 | 2014-02-03 | Ichimaru Pharcos Co Ltd | メラニン含有ケラチノサイト***促進剤 |
Non-Patent Citations (2)
Title |
---|
YAMAGUCHI YUJI, ET AL: "Dickkopf 1 (DKK1) regulates skin pigmentation and thickness by affecting Wnt/β-catenin signaling in", THE FASEB JOURNAL, vol. 22, JPN6019014953, April 2008 (2008-04-01), pages 1009 - 1020, ISSN: 0004269870 * |
YAMAGUCHI YUJI, ET AL: "Mesenchymal-epithelial interactions in the skin: increased expression of dickkopf1 by palmoplantar f", THE JOURNAL OF CELL BIOLOGY, vol. Volume 165, Number 2, JPN6019014951, 26 April 2004 (2004-04-26), pages 275 - 285, ISSN: 0004269869 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2019182845A (ja) * | 2018-04-02 | 2019-10-24 | 学校法人藤田学園 | キヌレニンアミノトランスフェラーゼ2(kat2)阻害剤 |
JP7454355B2 (ja) | 2018-12-27 | 2024-03-22 | ロート製薬株式会社 | Dkk1産生促進剤及びその製造方法、dkk1産生促進用美容組成物及びその製造方法、並びにdkk1産生促進方法 |
Also Published As
Publication number | Publication date |
---|---|
JP6846106B2 (ja) | 2021-03-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5137457B2 (ja) | 幹細胞増殖因子発現上昇抑制剤 | |
JP2009256270A (ja) | インスリン様成長因子−1発現促進剤 | |
KR101961152B1 (ko) | 양태반 분말과 식물의 복합물을 함유하는 피부 미백용, 피부 보습용 또는 피부주름 개선용 식품 또는 화장료 조성물 | |
KR101903745B1 (ko) | 탈모방지 또는 모발 성장 촉진용 조성물 | |
JP6846106B2 (ja) | Dkk1発現促進剤および美白剤 | |
JP2014221739A (ja) | Vii型コラーゲン発現促進剤 | |
JP2011001326A (ja) | エンドセリン−1mRNA発現抑制剤 | |
JP7402509B2 (ja) | Dkk1発現促進剤および美白剤 | |
JP2010215571A (ja) | エンドセリン−1mRNA発現上昇抑制剤、塩基性線維芽細胞増殖因子mRNA発現上昇抑制剤及びプロオピオメラノコルチンmRNA発現上昇抑制剤 | |
JP2016069341A (ja) | 皮膚バリア機能改善剤、細胞間接着構造の形成促進剤、タイトジャンクション形成促進剤及びtrpv4遺伝子の発現亢進剤 | |
JP2015086168A (ja) | リパーゼ阻害剤および皮脂コントロール用皮膚化粧料 | |
JP2022078258A (ja) | エンドセリン変換酵素阻害剤 | |
JP5896618B2 (ja) | メラニン産生抑制剤 | |
JP2011001328A (ja) | 塩基性線維芽細胞増殖因子mRNA発現上昇抑制剤 | |
JP6629271B2 (ja) | Endo180産生促進剤 | |
JP2011126824A (ja) | 脂肪蓄積抑制剤 | |
KR101310655B1 (ko) | 마름 추출물을 유효성분으로 포함하는 화장료 조성물 및 그 제조 방법 | |
JP2022023250A (ja) | Dkk1発現促進剤および美白剤 | |
JP2011032177A (ja) | Kit切断抑制剤 | |
JP2014040487A (ja) | 脂肪蓄積抑制剤 | |
KR20190062157A (ko) | 피지 조절 및 모공 축소용 조성물 | |
JP2019182753A (ja) | Endo180産生促進剤 | |
JP6017259B2 (ja) | エンドセリン作用抑制剤 | |
JP7315940B2 (ja) | 線維芽細胞増殖因子-5発現抑制剤 | |
JP7402478B2 (ja) | 神経成長因子発現抑制剤およびセマフォリン3a発現促進剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20180803 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20180803 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20190424 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20190507 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190705 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20191119 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200219 |
|
C60 | Trial request (containing other claim documents, opposition documents) |
Free format text: JAPANESE INTERMEDIATE CODE: C60 Effective date: 20200219 |
|
C11 | Written invitation by the commissioner to file amendments |
Free format text: JAPANESE INTERMEDIATE CODE: C11 Effective date: 20200303 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20200406 |
|
C21 | Notice of transfer of a case for reconsideration by examiners before appeal proceedings |
Free format text: JAPANESE INTERMEDIATE CODE: C21 Effective date: 20200407 |
|
A912 | Re-examination (zenchi) completed and case transferred to appeal board |
Free format text: JAPANESE INTERMEDIATE CODE: A912 Effective date: 20200529 |
|
C211 | Notice of termination of reconsideration by examiners before appeal proceedings |
Free format text: JAPANESE INTERMEDIATE CODE: C211 Effective date: 20200602 |
|
C22 | Notice of designation (change) of administrative judge |
Free format text: JAPANESE INTERMEDIATE CODE: C22 Effective date: 20201117 |
|
C23 | Notice of termination of proceedings |
Free format text: JAPANESE INTERMEDIATE CODE: C23 Effective date: 20210126 |
|
C03 | Trial/appeal decision taken |
Free format text: JAPANESE INTERMEDIATE CODE: C03 Effective date: 20210224 |
|
C30A | Notification sent |
Free format text: JAPANESE INTERMEDIATE CODE: C3012 Effective date: 20210224 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20210301 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6846106 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |